Clinical and lipid metabolic responses to diacylglycerol oil administration in Chinese adults with overweight/obesity or central obesity: a randomized, double-blind, placebo-controlled trial

Diacylglycerol (DAG) administration reduced small dense low-density lipoprotein cholesterol and hepatic steatosis and induced the enrichment of serum triacylglycerol and phosphatidylethanolamine species containing mono/polyunsaturated fatty acids.